{"altmetric_id":2682747,"counts":{"readers":{"mendeley":50,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[51890],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"Histaminergic H3 receptors may play a role in modulating cholinergic and monoaminergic neurotransmission. This Phase II study evaluated the efficacy and safety of GSK239512, a highly potent, brain penetrant H3 receptor antagonist as monotherapy treatment for subjects with mild-to-moderate probable Alzheimer's disease (AD).","abstract_source":"pubmed","altmetric_jid":"4f6fa4ea3cf058f61000265d","authors":["Grove RA","Harrington CM","Mahler A","Beresford I","Maruff P","Lowy MT","Nicholls A","Boardley R","Berges AC","Nathan PJ","Horrigan JP"],"first_seen_on":"2014-09-14T21:28:48+00:00","issns":["1567-2050"],"issue":"","journal":"Current Alzheimer Research","last_mentioned_on":1410719580,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24359500"],"pmid":"24359500","pubdate":"2013-12-25T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Neuroscience"],"subjects":["neurology"],"title":"A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H3 Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer's Disease.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/randomized-doubleblind-placebocontrolled-16week-study-hsub3sub-receptor-antagonist-gsk239512-monothe"},"altmetric_score":{"score":6.304,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":6.304},"context_for_score":{"all":{"total_number_of_other_articles":4249983,"mean":5.1322894703445,"rank":586392,"this_scored_higher_than_pct":86,"this_scored_higher_than":3662980,"rank_type":"exact","sample_size":4249983,"percentile":86},"similar_age_3m":{"total_number_of_other_articles":111673,"mean":8.3745112651337,"rank":20481,"this_scored_higher_than_pct":81,"this_scored_higher_than":91168,"rank_type":"exact","sample_size":111673,"percentile":81},"this_journal":{"total_number_of_other_articles":247,"mean":3.504918699187,"rank":68,"this_scored_higher_than_pct":72,"this_scored_higher_than":178,"rank_type":"exact","sample_size":247,"percentile":72},"similar_age_this_journal_3m":{"total_number_of_other_articles":18,"mean":1.8763529411765,"rank":2,"this_scored_higher_than_pct":88,"this_scored_higher_than":16,"rank_type":"exact","sample_size":18,"percentile":88}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":2,"Researcher":10,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":3,"Student  > Postgraduate":2,"Other":7,"Student  > Master":5,"Student  > Bachelor":11,"Lecturer":1,"Professor":5},"by_discipline":{"Medicine and Dentistry":13,"Neuroscience":4,"Social Sciences":1,"Psychology":15,"Agricultural and Biological Sciences":8,"Computer Science":1,"Nursing and Health Professions":1,"Mathematics":1,"Unspecified":5,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"NL":1,"US":1,"GB":1,"DE":1,"ES":2}}},"posts":{"blogs":[{"title":"News from ACTRIMS\/ECTRIMS 2014 Pharma in the hunt for remyelination","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/2014\/09\/news-from-actrimsectrims-2014-pharma-in.html","citation_ids":[2682744,2682745,4683958,2682746,2682747,5056878],"posted_on":"2014-09-14T18:33:00+00:00","summary":"#MS research Pharma led #remyelination trials ongoing RR Wang, Y Chen, T Guo, W Zhen, TB Guo, RY Zhao,AA Liu1, JP Rubio, D Krull, J Lu, M Song, P Thompson,S Wang1, JC Richardson.Histamine H3 receptor negatively regulates oligodendrocyte differentiation and","author":{"name":"Multiple Sclerosis Research","url":"http:\/\/multiple-sclerosis-research.blogspot.com\/","description":"A blog for people with MS and their families, by Barts and The London School of Medicine and Dentistry."}}]}}